Comments
The Board of Directors of the Company at their meeting held today, i.e. on May 30, 2019 had considered following: 1.Approved the Audited Standalone and Consolidated Financial Results along with Statement of Assets and Liabilities of the Company for the Quarter and Year Ended on March 31, 2019. 2.Auditors Report on Audited Standalone and Consolidated Financial Results for the Quarter and Year Ended on March 31, 2019 as received from M/s. J. T. Shah & Co., Statutory Auditors of the Company. 3.Recommended the Dividend of Rs. 1.50 (@ 15%) Per Share of Face Value of Rs. 10/- Each of the Company, subject to the approval of Shareholders at the Ensuring Annual General Meeting. 4.Declaration regarding Un-Modified Opinion on Audited Financial Results by the Statutory Auditors of the Company. 5.The Financial Performance Highlights for the Quarter and Year Ended on March 31, 2019.
Pdf Link: Lincoln Pharmaceuticals Ltd. - Result-Financial Result For The Quarter And Year Ended March 31, 2019
Source : BSE - www.bseindia.com
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.